Results 121 to 130 of about 5,024 (202)

Visible-light-responsive indoleazopyrazole photoswitches: dual enhancement of redshift and half-life by ester modification at the <i>ortho</i> position. [PDF]

Chem Sci
Yu X, Zhang C, Dong D, Liu B, Wang D, Li T.   +5 more
europepmc   +1 more source

Mn(III)-Mediated C–H Phosphorylation of Indazoles with Dialkyl Phosphites

ACS Omega, 2019
Payel Ghosh, Susmita Mondal, Alakananda Hajra   +2 more
doaj   +1 more source

Skeletal Editing Strategies Driven by Total Synthesis. [PDF]

Acc Chem Res
Kim SF, Amber C, Bartholomew GL, Sarpong R.   +3 more
europepmc   +1 more source

A Precise Synthetic Toolbox: H-Bond-Assisted Quadruple Reactivity of <i>o</i>-Dimethylaminoaryloximes. [PDF]

J Org Chem
Tsybulin SV, Meshalkin SA, Tonkoglazova DI, Bardakov VG, Pozharskii AF, Antonov AS.   +5 more
europepmc   +1 more source

Ir/Ni Metallaphotoredox Catalysis for the C(sp³)─H Bond α-Arylation and Alkylation of N-Alkyl N-Heterocycles. [PDF]

Chemistry
Lv B, Ling F, Soulé JF.
europepmc   +1 more source

Anticonvulsant action of indazole

Anticonvulsant action of indazole
Here we report that indazole is characterized as a potential anticonvulsant, inhibiting pentylenetetrazole-, electroshock- and strychnine-induced convulsions in mice (ED50's: 39.9, 43.2 and 82.4mg/kg, respectively) but not bicuculline- and picrotoxin-induced convulsions.
openaire  

Acquired MTAP Loss Following Entrectinib Resistance in ROS1-Rearranged NSCLC With CD74 Exon 3-ROS1 Exon 34 Fusion. [PDF]

Thorac Cancer
Haraguchi Hashiguchi M, Tanino M, Yoneda S, Asaoka M, Kagyo J, Katayama M, Terai H, Nakamura K, Nishihara H, Fukunaga K.   +9 more
europepmc   +1 more source

Regioselective Syntheses of Bis(indazolyl)methane Isomers: Controlling Kinetics and Thermodynamics via Tunable Non-Innocent Amines. [PDF]

ACS Omega
Álvarez-Sánchez M, Gómez M, Hurtado CS, Ngouné J, Álvarez E, Galindo A, Pettinari C.   +6 more
europepmc   +1 more source

Positive Allosteric Modulators for mGluR2 Receptors: A Medicinal Chemistry Perspective [PDF]

, 2014
Keserű, György Miklós, Szabó, György   +1 more
core   +1 more source

A Case Report of Promising Response to Combination Therapy With an Immune Checkpoint Inhibitor (Pembrolizumab) and Multi-Targeted Tyrosine Kinase Inhibitor (Pazopanib) in Metastatic De-Differentiated Chondrosarcoma. [PDF]

Cancer Rep (Hoboken)
Youssef M, Grimison P.
europepmc   +1 more source